Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib

Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib

Zhengxing Gao,1 Chunqing Song,2 Guangxin Li,1 Haishan Lin,1 Xiangyao Lian,1 Ninggang Zhang,1 Bangwei Cao11Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, People’s Republic of China; 2Department of Oncology, Beijing Daxing District Hopeople’...

Full description

Bibliographic Details
Main Authors: Gao Z, Song C, Li G, Lin H, Lian X, Zhang N, Cao B
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:OncoTargets and Therapy
Subjects:
pyrotinib
HER2
gastric cancer (GC)
exosome
human umbilical vein endothelial cells (HUVEC)
apatinib
Online Access:https://www.dovepress.com/pyrotinib-treatment-on-her2-positive-gastric-cancer-cells-promotes-the-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/pyrotinib-treatment-on-her2-positive-gastric-cancer-cells-promotes-the-peer-reviewed-article-OTT

Similar Items